Drug intelligence / Profile preview

SCB-1019T

Development stage
Unknown
Lead developer
Clover Biopharmaceuticals
Modality
Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
Administration
Intramuscular
01

Overview

SCB-1019T is Clover Biopharmaceuticals' investigational bivalent recombinant protein-subunit vaccine intended to prevent respiratory syncytial virus infection. It contains prefusion-stabilized respiratory syncytial virus fusion glycoprotein antigens representing RSV-A and RSV-B, produced as Trimer-Tag-fused recombinant F-trimer proteins in CHO cells. The vaccine is designed to induce neutralizing antibody responses against both RSV antigenic groups; it has been evaluated in Phase 1 studies in healthy adults, including revaccination of older adults previously vaccinated with AREXVY. ([cdek.pharmacy.purdue.edu](https://cdek.pharmacy.purdue.edu/trial/NCT06843317/))

Other names
Bivalent recombinant respiratory syncytial virus vaccine
02

Targets

RSV F (Respiratory syncytial virus fusion protein)

Beyond the preview

Go deeper on SCB-1019T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SCB-1019T.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call